Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $879,991 | 1 | 97.5% |
| Consulting Fee | $19,250 | 6 | 2.1% |
| Unspecified | $1,500 | 2 | 0.2% |
| Honoraria | $1,000 | 1 | 0.1% |
| Food and Beverage | $734.67 | 13 | 0.1% |
| Travel and Lodging | $332.32 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $879,991 | 1 | $0 (2018) |
| Janssen Research & Development, LLC | $13,819 | 13 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $4,250 | 3 | $0 (2017) |
| ModernaTX, Inc. | $2,000 | 2 | $0 (2022) |
| Navidea Biopharmaceuticals, Inc. | $1,500 | 2 | $0 (2018) |
| Jubilant Therapeutics Inc | $1,000 | 1 | $0 (2022) |
| Eli Lilly and Company | $247.98 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $247.98 | 2 | Eli Lilly and Company ($247.98) |
| 2022 | $3,000 | 3 | ModernaTX, Inc. ($2,000) |
| 2018 | $881,491 | 3 | Genentech USA, Inc. ($879,991) |
| 2017 | $18,069 | 16 | Janssen Research & Development, LLC ($13,819) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/10/2023 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 03/02/2023 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $122.98 | General |
| 07/18/2022 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 03/16/2022 | ModernaTX, Inc. | Moderna Covid-19 Vaccine (Biological) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Infections and Infectious Diseases | ||||||
| 02/09/2022 | Jubilant Therapeutics Inc | — | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| 11/29/2018 | Navidea Biopharmaceuticals, Inc. | — | — | Cash or cash equivalent | $500.00 | Research |
| 05/16/2018 | Navidea Biopharmaceuticals, Inc. | — | — | Cash or cash equivalent | $1,000.00 | Research |
| 02/28/2018 | Genentech USA, Inc. | Non-Covered Product (Drug) | Current or prospective ownership or investment interest | Cash or cash equivalent | $879,991.20 | General |
| Category: None | ||||||
| 11/30/2017 | Janssen Research & Development, LLC | — | Travel and Lodging | In-kind items and services | $332.32 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $125.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $50.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 11/30/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $15.00 | General |
| 10/10/2017 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $13,000.00 | General |
| 10/04/2017 | Janssen Research & Development, LLC | — | Food and Beverage | In-kind items and services | $6.69 | General |
| 04/13/2017 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,250.00 | General |
| 04/10/2017 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 03/05/2017 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 1 | 14 | 22 | $6,763 | $1,793 |
All Medicare Procedures & Services
1 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 22 | $6,763 | $1,793 | 26.5% |
About Dr. Gary Firestein, M.D
Dr. Gary Firestein, M.D is a Internal Medicine healthcare provider based in San Diego, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699790808.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Firestein, M.D has received a total of $902,808 in payments from pharmaceutical and medical device companies, with $247.98 received in 2023. These payments were reported across 24 transactions from 7 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($879,991).
As a Medicare-enrolled provider, Firestein has provided services to 14 Medicare beneficiaries, totaling 22 services with total Medicare billing of $1,793. Data is available for 1 year (2021–2021), covering 1 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Rheumatology
- Location San Diego, CA
- Active Since 07/12/2006
- Last Updated 09/11/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1699790808
Products in Payments
- Non-Covered Product (Drug) $879,991
- Moderna Covid-19 Vaccine (Biological) $2,000
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in San Diego
Dr. Bob Geng, M.d, M.D
Internal Medicine — Payments: $3.0M
Dr. Hatim Husain, Md, MD
Internal Medicine — Payments: $1.9M
Dr. Steven Edelman, M.d, M.D
Internal Medicine — Payments: $1.3M
Dr. Adam Zweig, Md, MD
Internal Medicine — Payments: $385,670
Dr. James Breitmeyer
Internal Medicine — Payments: $362,929
Dr. Bernard Michlin, M.d, M.D
Internal Medicine — Payments: $297,383